HGF and prostate carcinoma: According to Hsieh and Wu’s 2020 research, RES inhibited the release of hepatocyte growth factor (HGF) by stromal cells, which in turn impedes invasion and the epithelial–mesenchymal transition (EMT) in prostate cancer (PCa) cells [172].